Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn’s disease

Renske W. M. Pauwelsa Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The NetherlandsView further author information

Sebastiaan ten Bokkel Huininka Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands

Christien J. van der Woudea Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The NetherlandsView further author information

M. Doukasb Department of Pathology, Erasmus MC, Rotterdam, The NetherlandsView further author information

L. Oudijkb Department of Pathology, Erasmus MC, Rotterdam, The NetherlandsView further author information

Annemarie C. de Vriesa Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The NetherlandsCorrespondence[email protected] [email protected]
View further author information

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.